ID23516A - Alat-alat pengantaran obat dan metoda-metoda untuk perlakuan infeksi-infeksi yang disebabkan oleh virus dan mikroba dan sindrom-sindrom yang membahayakan. - Google Patents

Alat-alat pengantaran obat dan metoda-metoda untuk perlakuan infeksi-infeksi yang disebabkan oleh virus dan mikroba dan sindrom-sindrom yang membahayakan.

Info

Publication number
ID23516A
ID23516A IDW20000042A ID20000042A ID23516A ID 23516 A ID23516 A ID 23516A ID W20000042 A IDW20000042 A ID W20000042A ID 20000042 A ID20000042 A ID 20000042A ID 23516 A ID23516 A ID 23516A
Authority
ID
Indonesia
Prior art keywords
syndromes
viruses
microbial
dangerous
tools
Prior art date
Application number
IDW20000042A
Other languages
English (en)
Indonesian (id)
Inventor
Michelle Olga Patricia Visser
Original Assignee
Cryopreservation Tech Cc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Cryopreservation Tech Cc filed Critical Cryopreservation Tech Cc
Publication of ID23516A publication Critical patent/ID23516A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IDW20000042A 1997-06-13 1998-06-09 Alat-alat pengantaran obat dan metoda-metoda untuk perlakuan infeksi-infeksi yang disebabkan oleh virus dan mikroba dan sindrom-sindrom yang membahayakan. ID23516A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes

Publications (1)

Publication Number Publication Date
ID23516A true ID23516A (id) 2000-04-27

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000042A ID23516A (id) 1997-06-13 1998-06-09 Alat-alat pengantaran obat dan metoda-metoda untuk perlakuan infeksi-infeksi yang disebabkan oleh virus dan mikroba dan sindrom-sindrom yang membahayakan.

Country Status (34)

Country Link
EP (1) EP1011567A4 (ko)
JP (1) JP4531141B2 (ko)
KR (1) KR20010013709A (ko)
CN (1) CN1260703A (ko)
AP (1) AP1629A (ko)
AR (1) AR012970A1 (ko)
AU (1) AU7831598A (ko)
BG (1) BG103997A (ko)
BR (1) BR9810095A (ko)
CA (1) CA2295176A1 (ko)
CZ (1) CZ298510B6 (ko)
EA (1) EA200000011A1 (ko)
EE (1) EE9900562A (ko)
ES (1) ES2161187B1 (ko)
FI (1) FI19992648A (ko)
GB (1) GB2341319B (ko)
HU (1) HUP0003034A2 (ko)
ID (1) ID23516A (ko)
IL (2) IL133396A0 (ko)
IS (1) IS5289A (ko)
LT (1) LT4714B (ko)
LV (1) LV12490B (ko)
NO (1) NO996117L (ko)
NZ (1) NZ501669A (ko)
OA (1) OA11307A (ko)
PL (1) PL196256B1 (ko)
RO (1) RO121252B1 (ko)
SI (1) SI20191A (ko)
SK (1) SK172299A3 (ko)
TN (1) TNSN98086A1 (ko)
TR (1) TR200000540T2 (ko)
WO (1) WO1998056325A1 (ko)
YU (1) YU66099A (ko)
ZA (1) ZA984649B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070212402A1 (en) * 2003-12-05 2007-09-13 Rooven Qainton V Patch

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
WO1993016992A1 (en) * 1992-02-20 1993-09-02 Merrell Dow Pharmaceuticals Inc. Sulfonic acid derivatives in the treatment of viral diseases
SI9620126A (sl) * 1995-12-15 1999-10-31 Cryopreservation Technologies Cc (Za/Za) Spojina za kriogensko ohranjanje organov in zdravljenje virusnih ter bakterijskih infekcij

Also Published As

Publication number Publication date
HUP0003034A2 (hu) 2000-12-28
YU66099A (sh) 2002-10-18
GB2341319B (en) 2002-02-27
KR20010013709A (ko) 2001-02-26
LT99148A (en) 2000-07-25
PL196256B1 (pl) 2007-12-31
LT4714B (lt) 2000-10-25
CN1260703A (zh) 2000-07-19
ES2161187A1 (es) 2001-11-16
WO1998056325A1 (en) 1998-12-17
PL338439A1 (en) 2000-11-06
IL133396A0 (en) 2001-04-30
TR200000540T2 (tr) 2000-09-21
IS5289A (is) 1999-12-08
CZ9904473A3 (cs) 2001-03-14
NZ501669A (en) 2001-09-28
CA2295176A1 (en) 1998-12-17
NO996117D0 (no) 1999-12-10
IL133396A (en) 2006-10-05
AP9901708A0 (en) 1999-12-31
ZA984649B (en) 1999-12-17
TNSN98086A1 (fr) 2005-03-15
OA11307A (en) 2003-10-24
RO121252B1 (ro) 2007-02-28
EA200000011A1 (ru) 2000-08-28
NO996117L (no) 2000-02-11
AR012970A1 (es) 2000-11-22
JP4531141B2 (ja) 2010-08-25
ES2161187B1 (es) 2003-08-16
SI20191A (sl) 2000-10-31
GB9929189D0 (en) 2000-02-02
EE9900562A (et) 2000-06-15
AP1629A (en) 2006-07-11
EP1011567A1 (en) 2000-06-28
LV12490B (en) 2000-12-20
EP1011567A4 (en) 2000-06-28
AU7831598A (en) 1998-12-30
JP2002511862A (ja) 2002-04-16
BG103997A (en) 2001-07-31
CZ298510B6 (cs) 2007-10-24
SK172299A3 (en) 2000-09-12
GB2341319A (en) 2000-03-15
FI19992648A (fi) 2000-02-03
LV12490A (en) 2000-06-20
BR9810095A (pt) 2001-11-13

Similar Documents

Publication Publication Date Title
ID27787A (id) Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan
ID27457A (id) Komposisi untuk pengobatan hiv dan infeksi virus lainnya
EA200201263A1 (ru) СПОСОБЫ ЛЕЧЕНИЯ ИНФЕКЦИЙ, ВЫЗЫВАЕМЫХ ВИРУСОМ ГЕПАТИТА ДЕЛЬТА, С ИСПОЛЬЗОВАНИЕМ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
EA199901031A1 (ru) Производные бензимидазола
ATE295355T1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
WO2003053349A3 (en) Inhibitors of hepatitis c virus
DE60323077D1 (de) Immobilisierung und stabilisierung von viren
DK0973735T3 (da) Polyaromatiske antivirale præparater
AU2158000A (en) Treatment of hepatitis c virus infections with interleukin-10
PT1299395E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes provocadas por virus
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
CL2004000261A1 (es) Procedimiento para la eliminacion de virus en soluciones de fibrinogeno de aplicacion terapeutica.
ATE298569T1 (de) Virus behandlung
NO20022816L (no) Behandling av virale infeksjoner ved anvendelse av Levovirin
LV10191A (lv) Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai
DE60006412D1 (de) Oxazinochinolone zur behandlung von viralen infektionen
AU3858600A (en) Glucamine compounds for treating hepatitis virus infections
ID23516A (id) Alat-alat pengantaran obat dan metoda-metoda untuk perlakuan infeksi-infeksi yang disebabkan oleh virus dan mikroba dan sindrom-sindrom yang membahayakan.
FI965114A0 (fi) Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä
ID16598A (id) Metode pencegahan dan pengobatan penyakit-penyakit infeksi virus
NO20032769L (no) Kombinasjonsmetode for behandling av virale infeksjoner
ATE255594T1 (de) Hepatitis b inhibitoren
DE60011060D1 (de) Virus behandlung
EA200200927A1 (ru) Способ профилактики и лечения заболеваний иммунной системы и средство для его осуществления